Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Alnylam to Webcast Presentation at the Annual UBS Global Life Sciences Conference on September 27, 2005.


CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the annual UBS UBS Union Bank of Switzerland
UBS United Bible Societies
UBS United Blood Services
UBS United Buying Service
UBS Used Bookstore
UBS University Business Services
UBS Universal Building Society (UK)
UBS Ulaanbaatar Broadcasting System
 Global Life Sciences Conference on Tuesday, September 27, 2005, at 9:30 a.m. EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
 at the Grand Hyatt Hotel in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
.

A live audio webcast of this presentation will be available on the "Investors" section of the company's website, http://www.alnylam.com. A replay of the presentation will be posted on the Alnylam website approximately three hours after the event, and will be archived for 30 days.

About Alnylam

Alnylam is a biopharmaceutical company developing novel therapeutics based on a breakthrough in biology known as RNA interference RNA interference
n.
A process in which the introduction of double-stranded RNA into a cell inhibits the expression of genes.
, or RNAi. The company, founded in 2002 by scientific pioneers in the field of RNAi, maintains a leadership position in fundamental patents, technology, and know-how relating to RNAi. Alnylam is applying its expertise in RNAi to address multiple therapeutic opportunities that cannot effectively be addressed with small molecules or antibodies, the two current major classes of drugs. The company's expertise in designing and optimizing RNAi therapeutics has enabled Alnylam to form major alliances with leading companies including Merck and Medtronic. The company's global headquarters are in Cambridge, Massachusetts, with an additional operating unit operating unit

A type of operating company that engages in transactions with outsiders and that is owned by another business. For example, in 1995 the stockholders of Capital Cities/ABC approved a $19 billion merger with the Walt Disney Company, whereupon
 in Kulmbach, Germany. For more information, please visit www.alnylam.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Sep 20, 2005
Words:220
Previous Article:Morgan Keegan Announces New Banking Analysts in New York Office.
Next Article:William S. Rymer to Resign as Constar CFO Following Transition Period.
Topics:



Related Articles
Curis to Present at UBS Global Life Science Conference.
Axonyx Inc. to Present at The UBS Global Life Sciences Conference.
Alnylam to Host Conference Call to Discuss Novartis Collaboration.
UBS Global Life Sciences Conference to Webcast Flamel Technologies Corporate Presentation.
Aphton Announces Presentation at UBS Global Life Sciences Conference.
Curis to Present at the UBS 2005 Global Life Sciences Conference.
ICOS to Participate in the UBS Global Life Sciences Conference.
Regeneron Announces Presentation at UBS Global Life Sciences Conference.
BioSante Pharmaceuticals to Present at UBS Global Life Sciences Conference.
Alnylam to Webcast Presentation at Upcoming Investor Conferences.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles